Avacta Therapeutics has reported outcomes from the Phase Ia trial of AVA6000, a drug candidate for solid tumours.

Topline results from the Chinese portion of the trial for the antibody-drug conjugate (ADC) TIVDAK support the company’s regulatory plans.

Bollywood Star Saif Ali Khan was reportedly stabbed multiple times during a home invasion at his property in Mumbai on ...

The EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial cancer in adults.

An Orange County Superior Court judge Friday praised a proposed $233 million settlement with Disney in a class action suit ...

The 47th US president announced on his social media platform Truth Social at 12.38 am (5.38 am GMT) that four officials “not ...

The president ordered the withdrawal of the country from the Paris climate agreement and took action on immigration policy ...

JP Morgan analyst Matthew Boss reiterated an Overweight rating on the shares of Viking Holdings Ltd (NYSE:VIK) and raised the ...

Rifts with Hamas and a far-right minister’s threat to resign complicated progress toward the Israeli cabinet’s vote on the ...

Unlike the roles that some play on-screen, stars don't always get a happy ending. Too many famous figures die under ...